September 17th 2025
ACIP's upcoming meeting addresses vital vaccine updates, including COVID-19 and MMRV, while introducing new members to enhance public health transparency.
September 10th 2025
September 2nd 2025
Ghana is First To Approve ‘World-Changing’ Malaria Vaccine
May 3rd 2023Researchers have spent a century trying to develop a vaccine against malaria, one of the world’s biggest killers. The first shot to be approved, two years ago, is 30% effective. A new one, in the works for three decades, has a reported 77% efficacy and a licensee with the capacity to produce 200 million doses a year.
Read More
CDC Streamlines COVID-19 Vaccination Recommendations: One Shot for Adults Under 65, Two for Seniors
April 24th 2023The federal government is hoping that newly simplified vaccination guidelines will lead more Americans to get vaccinated against COVID-19. In other pandemic news, HHS announced plans to keep vaccines and treatments free for the uninsured, and an appellate court sided with the Biden administration's disputed vaccination requirement for federal contractors.
Read More
Vaccines to Protect the Young and the Old Against RSV Show Promising Results in Phase 3 trials
April 13th 2023Despite decades of research, no available vaccine targets respiratory syncytial virus (RSV), a disease that causes hundreds of thousands of deaths worldwide among young children and older adults. Interim results of two late-stage trials of Pfizer’sRSV prefusion F vaccine suggest the vaccine is efficacious, although the low RSV infection rates during the high COVID-19 pandemic years limited some of the findings.
Read More
The Nocebo Effect Found to Influence Adverse Effects of COVID-19 Vaccination
April 3rd 2023Vaccine hesitancy has many causes. A new study examined how the nocebo effect — beliefs that negative side effects will occur — may be a factor in people’s response to COVID-19 vaccination and could play into hesitancy dynamics.
Read More
Even with the end of polio in sight, ‘a single infectious virus can lead to a drastic resurgence’
March 16th 2023Global polio eradication efforts have reduced cases of the deadly disease by 99.99% in 35 years. Yet it continues to circulate in over 30 countries. The most dangerous form is endemic in Pakistan and Afghanistan, where it seeds outbreaks elsewhere.
Read More
Loosening Restrictions on Pharmacists Could Help Raise Children’s Vaccination Rates
March 10th 2023Increasing numbers of adults are getting vaccinated at pharmacies. But many states limit pharmacists’ ability to immunize children. Pharmacist participation in the federal Vaccines for Children program is even more restricted.
Read More
Vaccine Development: Turning Marathons in to 100-day Dashes
February 24th 2023It took less than a year to develop the first COVID-19 vaccine, but an epidemic preparation group has said even more speed could be added and proposed setting 100 days as a goal for the development of future vaccines,
Read More
WHO, CDC Have Different Recommendations When it Comes to HPV Vaccine Schedule
February 22nd 2023When it comes to the human papillomavirus (HPV) vaccine, organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend protection with the vaccine in different doses.
Read More
Fluvoxamine Effective Against COVID-19? Apparently Not Now.
January 12th 2023Results reported today on the JAMA website show no benefit from repurposing the SSRI as a COVID-19 treatment drug. Earlier results suggesting that fluvoxamine might be an effective treatment were from trials conducted earlier in the pandemic when vaccines weren’t available and other variants were circulating.
Read More
COVID-19 Vaccination and People with MS: T Cells Boosted, Antibodies Not So Much
September 5th 2022Research shows that patients with multiple sclerosis who have been treated with drugs that target CD20 B cells drugs, such as Ocrevus and Rituxan, tend to have a weak antibody response. But cellular immunity and T cells are activated. The results suggest a need for vaccines that boost T cells.
Read More